Clinical course and outcomes of COVID‐19 in hematopoietic cell transplant patients, a regional report from the Middle East - Poll - MDSpire

Clinical course and outcomes of COVID‐19 in hematopoietic cell transplant patients, a regional report from the Middle East

  • By

  • Riad El Fakih

  • Alfadil Haroon

  • Feras Alfraih

  • Murtadha K. Al-Khabori

  • Mohsen Alzahrani

  • Ahmad Alhuraiji

  • Abdulaziz Hamadah

  • Naif I. AlJohani

  • Bader Alahmari

  • Mohammed F. Essa

  • Ibraheem H. Motabi

  • Imran K. Tailor

  • Reem S. Almaghrabi

  • Khalil Al-Farsi

  • Ibraheem Abosoudah

  • Mouhab Ayas

  • Tusneem A. Elhassan

  • Ashraf M. Suhebeh

  • Syed Osman Ahmed

  • Saud Alhayli

  • Panayotis Kaloyannidis

  • Ahmad Alsaeed

  • Khalid Al Anezi

  • Sameer Alamoudi

  • Moussab Damlaj

  • Hani Al Hashmi

  • Mahmoud Aljurf

  • April 27, 2021

  • 0 min

Share

Original Source(s)

Clinical course and outcomes of COVID‐19 in hematopoietic cell transplant patients, a regional report from the Middle East

  • by Riad El Fakih, Alfadil Haroon, Feras Alfraih, Murtadha K. Al-Khabori, Mohsen Alzahrani, Ahmad Alhuraiji, Abdulaziz Hamadah, Naif I. AlJohani, Bader Alahmari, Mohammed F. Essa, Ibraheem H. Motabi, Imran K. Tailor, Reem S. Almaghrabi, Khalil Al-Farsi, Ibraheem Abosoudah, Mouhab Ayas, Tusneem A. Elhassan, Ashraf M. Suhebeh, Syed Osman Ahmed, Saud Alhayli, Panayotis Kaloyannidis, Ahmad Alsaeed, Khalid Al Anezi, Sameer Alamoudi, Moussab Damlaj, Hani Al Hashmi, Mahmoud Aljurf

  • April 27, 2021

Related Content

Persistence of an Infectious Form of SARS-CoV-2 After Protease Inhibitor Treatment of Permissive Cells In Vitro

Immune dysfunction prior to and during vaccination in multiple myeloma: a case study based on COVID-19

Viral infections and risk, in Wine and Medicine